”The nomination describes in detail how innovative work in Dr. Tapinos's laboratory has led to a broad array of advancements in the highly complex science of treating certain tumors. Intellectual property developed from his work includes drug delivery methods, techniques to lure migrating tumor cells towards targeted regions in the brain, development of novel antibodies for cancer therapy, development of RNA therapeutics against eRNA targets in glioblastoma and the identification of drugs now in preparation for human clinical trials.”
“Dr. Tapinos’s notable research grant awards include a current $4 million, four-year grant from the Alpert Foundation for which he is co-Primary Investigator, supporting, Investigation of the role of epigenetics in adult and pediatric malignant glioma.”
